| 摘要 |
<p>The invention relates generally to polymorphisms in the serotonin receptor 1D gene, the delta-opioid receptor gene, and the dopamine receptor D2 gene that are associated with eating disoders such as anorexia nervosa and bulimia nervosa. The invention also relates to composition screening systems and diagnostic and prognostic assays for eating disorders.</p> |
